[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE130304T1 - Neue alpha-glukosidaseinhibitoren. - Google Patents

Neue alpha-glukosidaseinhibitoren.

Info

Publication number
ATE130304T1
ATE130304T1 AT91912140T AT91912140T ATE130304T1 AT E130304 T1 ATE130304 T1 AT E130304T1 AT 91912140 T AT91912140 T AT 91912140T AT 91912140 T AT91912140 T AT 91912140T AT E130304 T1 ATE130304 T1 AT E130304T1
Authority
AT
Austria
Prior art keywords
glucosidasine
inhibitors
new alpha
alpha
new
Prior art date
Application number
AT91912140T
Other languages
English (en)
Inventor
Jean-Bernard Ducep
Charles Danzin
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of ATE130304T1 publication Critical patent/ATE130304T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Child & Adolescent Psychology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT91912140T 1990-06-08 1991-05-17 Neue alpha-glukosidaseinhibitoren. ATE130304T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90401582 1990-06-08

Publications (1)

Publication Number Publication Date
ATE130304T1 true ATE130304T1 (de) 1995-12-15

Family

ID=8205720

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91912140T ATE130304T1 (de) 1990-06-08 1991-05-17 Neue alpha-glukosidaseinhibitoren.

Country Status (7)

Country Link
EP (1) EP0532668B1 (de)
JP (1) JP3136491B2 (de)
AT (1) ATE130304T1 (de)
AU (1) AU8069891A (de)
DE (1) DE69114707T2 (de)
ES (1) ES2082212T3 (de)
WO (1) WO1991018915A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536732A (en) * 1990-04-27 1996-07-16 Merrell Pharmaceuticals Inc. N-derivatives of 1-deoxy nojirimycin
US5252587A (en) * 1990-04-27 1993-10-12 Merrell Dow Pharmaceuticals, Inc. N-derivatives of 1-deoxy nojirimycin
WO1995001361A1 (fr) * 1993-07-02 1995-01-12 Nippon Shinyaku Co., Ltd. Derive de galactosylmoranoline
WO1995006057A1 (fr) * 1993-08-23 1995-03-02 Nippon Shinyaku Co., Ltd. Derive de galactosylmoraniline
US5633233A (en) * 1995-06-07 1997-05-27 Alberta Research Council Modified kojibiosides analogues
EP1746992A2 (de) * 2004-03-25 2007-01-31 United Therapeutics Verwendung von n-substituierten iminozuckern zur unterdrückung des appetits

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6055078B2 (ja) * 1980-12-01 1985-12-03 日本新薬株式会社 モラノリンの誘導体
GB2181729B (en) * 1985-10-12 1990-04-04 Nippon Shinyaku Co Ltd Glucosylmoranoline derivatives and production thereof
JPS62242692A (ja) * 1986-04-15 1987-10-23 Nippon Shinyaku Co Ltd モラノリン誘導体の製造法
JP2504000B2 (ja) * 1986-09-02 1996-06-05 日本新薬株式会社 グルコシルモラノリン誘導体

Also Published As

Publication number Publication date
EP0532668B1 (de) 1995-11-15
EP0532668A1 (de) 1993-03-24
AU8069891A (en) 1991-12-31
JPH05509082A (ja) 1993-12-16
WO1991018915A1 (en) 1991-12-12
ES2082212T3 (es) 1996-03-16
DE69114707D1 (de) 1995-12-21
JP3136491B2 (ja) 2001-02-19
DE69114707T2 (de) 1996-06-13

Similar Documents

Publication Publication Date Title
TR200200068T2 (tr) Nematisital triflüorobütenler
DE69133397D1 (de) Benzoylderivate
DK162770C (da) Analogifremgangsmaade til fremstilling af 3,20-dioxo-1,4-pregnadien-17alfa-ol-17-heteroaromatiske carboxylater
FI890311A0 (fi) Kemiska foereningar.
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
AR010385A1 (es) Compuesto derivado de propiofenona, proceso para su preparacion, composicion farmaceutica que lo contiene y uso de dicho compuesto.
ATE116848T1 (de) Verwendung von baclofen zur herstellung von arzneimitteln zur behandlung von angina pectoris.
CO4290432A1 (es) Nuevos derivados de pirazinacarboxamida, su preparacion y su utilizacion en medicamentos.
DK0473671T3 (da) Anvendelse af sigma-receptorligander til fremstilling af et anxiolytisk middel
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
DE68918217D1 (de) Familie von modifizierten Antikörpern mit hoher Affinität zur Behandlung von Krebs.
ATE11547T1 (de) Neue d-homosteroide, ihre verwendung und herstellung, sowie pharmazeutische praeparate damit.
DK0489877T3 (da) Antiatherosklerotiske og antithrombotiske 2-amino-6-phenyl-4H-pyran-4-oner
DE69010294D1 (de) Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs.
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ATE130304T1 (de) Neue alpha-glukosidaseinhibitoren.
DK0471718T3 (da) Paracetamolholdigt farmaceutisk præparat
NO993360D0 (no) Anvendelse av pramipeksol ved behandling av "restless leg"- syndromet
NO970573D0 (no) Ylidenforbindelser og deres fremstilling
TR26931A (tr) Lak koagülasyonunda molipten bilesiklerinin kullanilmasi.
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
DE58909244D1 (de) Verwendung von 1,4-Dihydropyridin-Derivaten in der Behandlung von Alkoholsucht.
DE3668116D1 (de) Zusammensetzung zur behandlung von infektionen.
DK0522001T3 (da) Understøttende anvendelse af Linomide
DE59008844D1 (de) Benzylselenobenzamide von Aminopyridinen und Picolylaminen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time